Can low ferritin with low-normal hemoglobin and elevated RDW reflect early iron-restricted red blood cell production?

Iron deficiency develops through a systematic, multi-stage physiological progression before manifesting as clinical anemia.

Hematological and mechanistic progression

• Stage 1 (Iron depletion): Marked by low serum ferritin, reflecting depleted storage iron while hemoglobin remains normal.
• Stage 2 (Iron-restricted erythropoiesis): As storage iron is exhausted, the bone marrow's erythroid progenitors lack the iron required for heme synthesis. This initiates latent, non-anemic iron-restricted erythropoiesis.
• Stage 3 (Overt anemia): If untreated, prolonged restricted erythropoiesis progresses to Stage 3, marked by clinically low hemoglobin and overt iron deficiency anemia.

Indicators of uneven red cell production

• Elevated RDW (Anisocytosis): Restricted heme synthesis causes newly produced cells to be microcytic and hypochromic. The mixture of these new cells with existing normocytic cells increases red cell distribution width (RDW), often serving as the earliest cellular marker of restricted erythropoiesis.
• Declining indices: Concurrently, mean corpuscular hemoglobin concentration (MCHC) and red blood cell (RBC) count decrease, driving hemoglobin toward low-normal levels before formal clinical criteria for anemia are met.

Bottom line

• A profile of low ferritin, low-normal hemoglobin, low RBC, low MCHC, and elevated RDW clinically reflects active, non-anemic iron-restricted erythropoiesis, presenting a crucial diagnostic window for early therapeutic intervention before the onset of overt anemia.